Inventage Lab (389470.KQ) Akcie Kurz

Inventage Lab, Inc. researches and develops biotechnology. The company is headquartered in Seongnam, Gyeonggi-Do and currently employs 66 full-time employees. The company went IPO on 2022-11-22. The firm owns the platforms applied to the development and mass production of long-acting injections and drug delivery of genetic materials. The firm is engaged in the research, manufacture and sale of human medicines used for male pattern baldness, dementia, prostate cancer and others. The company is also engaged in the research, manufacture and sale of veterinary medicines such as combination drugs, chemical castration agents and others.